Molecular architecture of the neuromuscular junction

Muscle and Nerve

Volumn 33, Issue 4, 2006, Pages 445-461

  Hughes, Benjamin W ^a   Kusner, Linda L ^a   Kaminski, Henry J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Acetylcholine; Acetylcholine receptor; Congenital myasthenic syndromes; Lambert Eaton myasthenic syndrome; Muscle specific kinase; Myasthenia gravis; Neuromuscular junction; Neuromuscular transmission

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CELL PROTEIN; CHOLINERGIC RECEPTOR; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; VOLTAGE GATED SODIUM CHANNEL;

ANATOMY; BASEMENT MEMBRANE; CELL COMMUNICATION; CELL FUNCTION; CELL ORGANELLE; CELL ULTRASTRUCTURE; ENDPLATE POTENTIAL; HUMAN; MEMBRANE POTENTIAL; MOTOR NERVE; MUSCLE CONTRACTION; MUSCLE FIBER MEMBRANE; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SCHWANN CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SYNAPTIC MEMBRANE;

ANIMALS; HUMANS; NEUROMUSCULAR DISEASES; NEUROMUSCULAR JUNCTION; RECEPTORS, PRESYNAPTIC; SYNAPTIC TRANSMISSION;

EID: 33645330973     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20440     Document Type: Review

References (165)

1. Anderson MJ, Cohen MW. Nerve-induced and spontaneous redistribution of acetylcholine receptors on cultured muscle cells. J Physiol (Lond) 1977;268:757-773.
2. Apel ED, Glass DJ, Moscoso LM, Yancopoulos GD, Sanes JR. Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. Neuron 1997;18:623-635.
3. Augustine GJ, Adler EM, Charlton MP. The calcium signal for transmitter secretion from presynaptic nerve terminals. Ann NY Acad Sci 1991;635:365-381.
4. Auld DS, Robitaille R. Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation. Neuroscientist 2003;9:144-157.
5. Bennet MR. The concept of transmitter receptors: 100 years on. Neuropharmacology 2000;39:523-546.
6. Bevan S, Steinbach JH. The distribution of alpha-bungarotoxin binding sites of mammalian skeletal muscle developing in vivo. J Physiol (Lond) 1977;267:195-213.
7. Boonyapisit K, Kaminski HJ, Ruff RL. The molecular basis of neuromuscular transmission disorders. Am J Med 1999;106:97-113.
8. Borst JG, Sakmann B. Calcium influx and transmitter release in a fast CNS synapse. Nature 1996;383:431-434.
9. Brejc K, van Dijk WJ, Klaassen RV, Schuurman M, van der Oost J, Smit AB, et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001;411:269-276.
10. Briguet A, Ruegg MA. The Ets transcription factor GABP is required for postsynaptic differentiation in vivo. J Neurosci 2000;20:5989-5996.
11. Bunge RP. The role of the Schwann cell in trophic support and regeneration. J Neurol 1994;242(suppl):S19-S21.
12. Burden S, Yarden Y. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 1997;18:847-855.
13. Burden SJ, DePalma RL, Gottesman GS. Crosslinking of proteins in acetylcholine receptor-rich membranes: association between the beta-subunit and the 43 kd subsynaptic protein. Cell 1983;35:687-692.
14. Burke G, Cossins J, Maxwell S, Owens G, Vincent A, Robb S, et al. Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes. Neurology 2003;61:826-828.
15. Byring RF, Pihko H, Tsujino A, Shen XM, Gustafsson B, Hackman P, et al. Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. Neuromuscul Disord 2002;12:548-553.
16. Chao DS, Silvagno P, Xia H, Cornwell TL, Lincoln TM, Bredt DS. Nitric oxide synthase and cyclic GMP-dependent protein kinase concentrated at the neuromuscular endplate. Neuroscience 1997;76:665-672.
17. Chung W, Campanelli JT. WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding. Mol Cell Biol Res Commun 1999;2:162-171.
18. Cohen I, Rimer M, Lomo T, McMahan UJ. Agrin-induced postsynaptic-like apparatus in skeletal muscle fibers in vivo. Mol Cell Neurosci 1997;9:237-253.
19. Cohen MW, Godfrey EW. Early appearance of and neuronal contribution to agrin-like molecules at embryonic frog nerve-muscle synapses formed in culture. J Neurosci 1992;12:2982-2992.
20. Connor EA, Dunaevsky A, Griffiths DJ, Hardwick JC, Parsons RL. Transmitter release differs at snake twitch and tonic endplates during potassium-induced nerve terminal depolarization. J Neurophysiol 1997;77:749-760.
21. Connor EA, Fiekers JF, Neel DS, Parsons RL, Schnitzler RM. Comparison of cholinergic activation and desensitization at snake twitch. J Physiol (Lond) 1984;351:657-674.
22. Couteaux R. Localization of cholinesterase at neuromuscular junctions. Int Rev Cytol 1955;5:335-375.
23. Dai Z, Peng HB. Fluorescence microscopy of calcium and synaptic vesicle dynamics during synapse formation in tissue culture. Histochem J 1998;30:189-196.
24. 2+ uptake prevents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals. J Physiol (Lond) 2003;548:425-438.
25. 2+] in stimulated motor nerve terminals. Cell Calcium 2003;33:197-206.
26. DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996;85:501-512.
27. Denzer AJ, Brandenberger R, Gesemann M, Chiquet M, Ruegg MA. Agrin binds to the nerve-muscle basal lamina via laminin. J Cell Biol 1997;137:671-683.
28. Dionne VE. Two types of nicotinic acetylcholine receptor channels at slow fibre end-plates of the garter snake. J. Physiol (Lond) 1989;409:313-331.
29. Dionne VE, Leibowitz MD. Acetylcholine receptor kinetics: a description from single-channel currents at snake neuromuscular junction. Biophys J 1982;39:253-261.
30. Doyere L. Memoire sur de les tardigrades. Ann Sci Nat Zool 1840;14:269-361.
31. Engel A. The myasthenic syndromes. Oxford: Oxford University Press; 1999.
32. Engel AG. Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Ann NY Acad Sci 1991;635:246-258.
33. Engel AG, Ohno K, Bouzat C, Sine SM, Griggs RC. End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit. Ann Neurol 1996;40:810-817.
34. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: recent advances. Arch Neurol 1999;56:163-167.
35. Erecinska M, Silver IA. Ions and energy in mammalian brain. Prog Neurobiol 1994;43:37-71.
36. Fessard A. Claude Bernard and the physiology of junctional transmission. In: Grande F, Visscher MB, eds. Claude Bernard and experimental medicine. Cambridge, MA: Schenkman; 1967. p 105-124.
37. Fischbach GD, Rosen KM. ARIA: a neuromuscular junction neuregulin. Annu Rev Neurosci 1997;20:429-458.
38. Frank E, Fischbach GD. Early events in neuromuscular junction formation in vitro: induction of acetylcholine receptor clusters in the postsynaptic membrane and morphology of newly formed synapses. J Cell Biol 1979;83:143-158.
39. Froehner SC. The submembrane machinery for nicotinic acetylcholine receptor clustering. J Cell Biol 1991;114:1-7.
40. Fromm L, Burden SJ. Synapse-specific and neuregulin-induced transcription require an ets site that binds GABPalpha/GABPbeta. Genes Dev 1998;12:3074-3083.
41. Fukunaga H, Engel AG, Osame M, Lambert EH. Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1982;5:686-697.
42. Fukuoka T, Engel AG, Lang B, Newsom-Davis J, Prior C, Wray DW. Lambert-Eaton myasthenic syndrome: I. Early morphologic effects of IgG on the presynaptic membrane active zones. Ann Neurol 1987;22:193-199.
43. Fukuoka T, Engel AG, Lang B, Newsom-Davis J, Vincent A. Lambert-Eaton myasthenic syndrome. II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate. Ann Neurol 1987;22:200-211.
44. Galli T, Haucke V. Cycling of synaptic vesicles: how far? How fast! Sci STKE 2004;2004:rel9.
45. Gandhi SP, Stevens CF. Three modes of synaptic vesicular recycling revealed by single-vesicle imaging. Nature 2003;423:607-613.
46. Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie JP, et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 1996;85:525-535.
47. Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, Sanes JR, et al. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 1995;377:232-236.
48. Gerst JW, Brumback RA. Neuromuscular transmission: early historical development of the concept. In: Brumback RA, Gerst JW, editors. The neuromuscular junction. Mount Kisco, NY: Futura; 1984. p 1-23.
49. Gertler RA, Robbins N. Differences in neuromuscular transmission in red and white muscles. Brain Res 1978;142:255-284.
50. Glass DJ, Bowen DC, Stitt TN, Radziejewski C, Bruno J, Ryan TE, et al. Agrin acts via a MuSK receptor complex. Cell 1996;85:513-523.
51. Gomes FC, Spohr TC, Martinez R, Moura Neto RV. Cross-talk between neurons and glia: highlights on soluble factors. BrazJ Med Biol Res 2001;34:611-620.
52. Gomez C, Bhattacharyya B, Charnet P, Day JW, Labarca C, Wollmann RL, et al. A transgenic mouse model of the slow-channel syndrome. Muscle Nerve 1996;19:79-87.
53. Gomez C, Masselli R, Gundeck J, Chao M, Day JW, Tamamizu S, et al. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci 1997;17:4171-4179.
54. Gramolini AO, Angus LM, Schaeffer L, Burton EA, Tinsley JM, Davies KE, et al. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc Natl Acad Sci USA 1999;96:3223-3227.
55. Han Y, Wang J, Fischman DA, Biller HF, Sanders I. Slow tonic muscle fibers in the thyroarytenoid muscles of human vocal folds; a possible specialization for speech. Anat Rec 1999;256:146-157.
56. Henry MD, Campbell KP. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 1996;8:625-631.
57. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368.
58. Horton RM, Manfredi AA, Conti-Tronconi BM. The "embryonic" gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle. Neurology 1993;43:983-986.
59. Hughes B, Moro De Casillas M, Kaminski H. Myasthenia gravis- pathophysiology of neuromuscular transmission. Semin Neurol 2004;24:21-30.
60. Hutchinson DO, Engel AG, Walls TJ, Nakano S, Camp S, Taylor P, et al. The spectrum of congenital end-plate acetylcholinesterase deficiency. Ann NY Acad Sci 1993;681:469-486.
61. Jirmanova I. Ultrastructure of motor end-plates during pharmacologically-induced degeneration and subsequent regeneration of skeletal muscle. J Neurocytol 1975;4:141-155.
62. Jones G, Meier T, Lichtsteiner M, Witzemann V, Sakmann B, Brenner HR. Induction by agrin of ectopic and functional postsynaptic-like membrane in innervated muscle. Proc Natl Acad Sci USA 1997;94:2654-2659.
63. Kaminski H, Kusner L, Pressly J, Ruff R. The fetal acetylcholine receptor is found in both single- and multi-innervated extraocular muscle fibers. Invest Ophthomol Vis Sci 1995;36(suppl):S959.
64. Kaminski HJ (editor). Myasthenia gravis and related disorders. Totowa, NJ: Humana Press; 2003. 396 p.
65. Kaminski HJ, Kusner LL, Block CH. Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest Ophthalmol Vis Sci 1996;37:345-351.
66. Kaminski HJ, Kusner LL, Nash KV, Ruff RL. The γ-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris. Neurology 1995;45:516-518.
67. Kaminski HJ, Li Z, Richmonds C, Ruff RL, Kusner L. Susceptibility of ocular tissues to autoimmune diseases. Ann NY Acad Sci 2003;998:362-374.
68. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 2002;3:102-144.
69. Katz B, Miledi R. The binding of acetylcholine to receptors and its removal from the synpatic cleft. J Physiol (Lond) 1973;231:549-574.
70. Katz B, Miledi R. Estimates of quantal content during chemical potentiation of transmitter release. Proc R Soc Lond 1979;205:369-378.
71. Khanna S, Porter JD. Conservation of synapse-signaling pathways at the extraocular muscle neuromuscular junction. Ann NY Acad Sci 2002;956:394-396.
72. Khurana TS, Rosmarin AG, Shang J, Krag TO, Das S, Gammeltoft S. Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta. Mol Biol Cell 1999;10:2075-2086.
73. Koirala S, Reddy LV, Ko CP. Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J Neurocytol 2003;32:987-1002.
74. Kong XC, Barzaghi P, Ruegg MA. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep 2004;5:183-188.
75. Krejci E, Coussen F, Duval N, Chatel JM, Legay C, Puype M, et al. Primary structure of a collagenic tail peptide of Torpedo acetylcholinesterase: co-expression with catalytic subunit induces the production of collagen-tailed forms in transfected cells. EMBO J 1991;10;1285-1293.
76. Krejci E, Thomine S, Boschetti N, Legay C, Sketelj J, Massoulie J. The mammalian gene of acetylcholinesterase-associated collagen. J Biol Chem 1997;272:22840-22847.
77. Kusner LL, Kaminski HJ. Nitric oxide synthase is concentrated at the skeletal muscle endplate. Brain Res 1996;730:238-242.
78. Land BR, Harris WV, Salpeter EE, Salpeter MM. Diffusion and binding constants for acetylcholine derived from the falling phase of miniature endplate currents. Proc Natl Acad Sci USA 1984;81:1594-1598.
79. Langley JN. On the reaction of cells and of nerve endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curare. J Physiol 1905;33:374-413.
80. Lin W, Sanchez HB, Deerinck T, Morris JK, Ellisman M, Lee KF. Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc Natl Acad Sci USA 2000;97:1299-1304.
81. Lindstrom J. Acetylcholine receptor structure. In: Kaminski HJ, editor. Myasthenia gravis and related disorders. Totowa, NJ: Humana Press, 2003. p 15-52.
82. Lindstrom J. Acetylcholine receptors and myasthenia. Muscle Nerve 2000;23:453-477.
83. Liyanage Y, Hoch W, Beeson D, Vincent A. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 2002;25:4-16.
84. Madhavan R, Zhao XT, Ruegg MA, Peng HB. Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering. Mol Cell Neurosci 2005;28:403-416.
85. Marques MJ, Santo Neto H. Imaging neuromuscular junctions by confocal fluorescence microscopy: individual endplates seen in whole muscles with vital intracellular staining of the nerve terminals. J Anat 1998;192:425-430.
86. Martin AR. Amplification of neuromuscular transmission by postjunctional folds. Proc R Soc Lond B 1994;258:321-326.
87. Maselli RA, Soliven BC. Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: paradoxical response to edrophonium and D-tubocurarine. Muscle Nerve 1991;14:1182-1188.
88. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992;360:588-591.
89. McMahan LJ, Sanes JR, Marshall LM. Cholinesterase is associated with the basal lamina at the neuromuscular junction. Nature 1978;271:172-174.
90. Melamed N, Helm PJ, Rahamimoff R. Confocal microscopy reveals coordinated calcium fluctuations and oscillations in synaptic boutons. J Neurosci 1993;13:632-649.
91. Merlie JP, Sanes JR. Concentration of acetylcholine receptor mRNA in synaptic regions of adult muscle fibers. Nature 1985;317:66-68.
92. Milton RL, Lupa MT, Caldwell JH. Fast- and slow-twitch skeletal muscle fibres differ in their distributions of Na channels near the endplate. Neurosci Lett 1992;135:41-44.
93. Missias AC, Chu GC, Klocke BJ, Sanes JR, Merlie JP. Regulation of the acetylcholine receptor gamma subunit gene in developing skeletal muscle: analysis with subunit-specific antibodies, transgenic mice, and cultured cells. Dev Biol 1996;179:223-238.
94. Mora M, Lambert EH, Engel AG. Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 1987;37:206-214.
95. Morgan DL, Proske U. Vertebrate slow muscle: its structure, pattern of innervation, and mechanical properties. Physiol Rev 1984;64:103-169.
96. Muley S, Gomez CM. Congenital myasthenic syndromes. In: Kaminski HJ, editor. Myasthenia gravis and related disorders. Totowa, NJ: Humana Press; 2003.
97. Noakes PG, Phillips WD, Hanley TA, Sanes JR, Merlie JP. 43k protein and acetylcholine receptors colocalize during the initial stages of neuromuscular synapse formation in vivo. 1993;155:275-280.
98. Ohno K, Engel AG, Shen XM. Rapsyn mutations in humans cause endplate acetylcholine receptor deficiency and myasthenic syndrome. J Hum Genet 2002;70:875-885.
99. Ohno K, Sadeh M, Blatt I, Brengman JM, Engel AG. E-box mutations in RAPSN promoter region in eight cases with congenital myasthenic syndrome. Hum Mol Genet 2003;12:739-748.
100. Ohno K, Wang HL, Milone M. Congenital myasthenic syndrome caused by decreased agonist binding due to mutaion in the acetylcholine receptor epsilon subunit. Neuron 1996;17:157-170.
101. Patton BL. Basal lamina and the organization of neuromuscular synapses. J Neurocytol 2003;32:883-903.
102. Peng HB, Ali AA, Dai Z, Daggett DF, Raulo E, Rauvala H. The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells. J Neurosci 1995;15:3027-3038.
103. Peng HB, Baker LP, Chen Q. Induction of synaptic development in cultured muscle cells by basic fibroblast growth factor. Neuron 1991;6:237-246.
104. Phillips WD, Noakes PG, Roberds SL, Campbell KP, Merlie JP. Clustering and immobilization of acetylcholine receptors by the 43-kD protein, a possible role for dystrophin-related protein. J Cell Biol 1993;123:729-740.
105. Plomp JJ, Van Kempen GT, De Baets MB, Graus YM, Kuks JB, Molenaar PC. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Ann Neurol 1995;37:627-636.
106. Poage RE, Meriney SD. Presynaptic calcium influx, neurotransmitter release, and neuromuscular disease. Physiol Behav 2002;77:507-512.
107. Porter JD. Extraocular muscle: cellular adaptations for a diverse functional repertoire. Ann NY Acad Sci 2002;956:7-16.
108. Pun S, Sigrist M, Santos AF, Ruegg MA, Sanes JR, Jessell TM, et al. An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron 2002;34:357-370.
109. Ramarao MK, Cohen JB. Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn. Proc Natl Acad Sci USA 1998;95:4007-4012.
110. Rauvala H, Peng HB. HB-GAM (heparin-binding growth-associated molecule) and heparin-type glycans in the development and plasticity of neuron-target contacts. Prog Neurobiol 1997;52:127-144.
111. Reddy LV, Koirala S, Sugiura Y, Herrera AA, Ko CP. Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. Neuron 2003;30:563-580.
112. Reist NE, Smith SJ. Neurally evoked calcium transients in terminal Schwann cells at the neuromuscular junction. Proc Natl Acad Sci USA 1992;89:7625-7629.
113. Richards DA, Guatimosim C, Rizzoli SO, Betz WJ. Synaptic vesicle pools at the frog neuromuscular junction. Neuron 2003;39:529-541.
114. Rizzoli SO, Betz WJ. The structural organization of the readily releasable pool of synaptic vesicles. Science 2004;303:2037-2039.
115. Robitaille R. Purinergic receptors and their activation by endogenous purines at perisynaptic glial cells of the frog neuromuscular junction. J Neurosci 1995;15:7121-7131.
116. Rochon D, Rousse I, Robitaille R. Synapse-glia interactions at the mammalian neuromuscular junction. J Neurosci 2001;21:3819-3829.
117. Ruegg MA, Bixby JL. Agrin orchestrates synaptic differentiation at the vertebrate neuromuscular junction. Trends Neurosci 1998;21:22-27.
118. Na and excitability near and far from the endplate. Muscle Nerve 1996;19:1084-1092.
119. Ruff R. Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibers enable the performance properties of different skeletal muscle fiber types. Acta Physiol Scand 1996;156:159-168.
120. Ruff RL. Na current density at and away from end plates on rat fast- and slow-twitch skeletal muscle fibers. Am J Physiol 1992;262:C229-C234.
121. Ruff RL. Neurophysiology of the neuromuscular junction: overview. Ann NY Acad Sci 2003;998:1-10.
122. Ruff RL, Kaminski HJ, Maas E, Spiegel P. Ocular muscles: physiology and structure-function correlations. Bull Soc Belg Ophthalmol 1989;237:321-352.
123. Ruff RL, Lennon V. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ann Neurol 1998;43:370-379.
124. Rupp F, Payan DG, Magill-Solc C, Cowan DM, Scheller RH. Structure and expression of a ratagrin. Neuron 1991;6:811-823.
125. Sahashi K, Engel AG, Lambert EH, Howard FM Jr. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol 1980;39:160-172.
126. Salpeter MM. Vertebrate neuromuscular junctions: general morphology, molecular organization, and functional consquences. In: Salpeter MM, editor. Neurology and neurobiology. Vol. 23. New York: Alan R. Liss; 1987. p 1-54.
127. Sandbank U, Bubis JJ. The morphology of motor endplates. Los Angeles, CA: Brain Information Service/Brain Research Institute; 1974.
128. Sanes JR. The basement membrane/basal lamina of skeletal muscle. J Biol Chem 2003;278:12601-12604.
129. Sanes JR, Lichtman JW. Development of the vertebrate neuromuscular junction. Annu Rev Neurosci 1999;22:389-442.
130. Sapru MK, Florance SK, Kirk C, Goldman D. Identification of a neuregulin and protein-tyrosine phosphatase response element in the nicotinic acetylcholine receptor epsilon subunit gene: regulatory role of an Rts transcription factor. Proc Natl Acad Sci USA 1998;95:1289-1294.
131. Schaeffer L, Duclert N, Huchet-Dymanus M, Changeux JP. Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor. EMBO J 1998;17:3078-3090.
132. Seagar M, Leveque C, Charvin N, Marqueze B, Martin-Moutot N, Boudier JA, et al. Interactions between proteins implicated in exocytosis and voltage-gated calcium channels. Phil Trans R Soc Lond B 1999;354:289-297.
133. Sealock R, Wray BE, Froehner SC. Ultrastructural localization of the Mr 43,000 protein and the acetylcholine receptor in Torpedo postsynaptic membranes using monoclonal antibodies. J Cell Biol 1984;98:2239-2244.
134. Selcen D, Fukuda T, Shen XM, Engel AG. Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 2004;62:1945-1950.
135. Shiraishi H, Motomura M, Yoshimura T, Fukudome T, Fukuda T, Nakao Y, et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005;57:289-293.
136. Simon BJ, Klein MG, Schneider MF. Calcium dependence of inactivation of calcium release from the sarcoplasmic reticulum in skeletal muscle fibers. J Gen Physiol 1991;97:437-471.
137. Sine S, Ohno K, Bouzat, C, Auerbach A, Milone M, Pruit JN, et al. Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 1995;15:229-239.
138. Sine SM, Shen XM, Wang HL, Ohno K, Lee WY, Tsujino A, et al. Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating. J Gen Physiol 2002;120:483-496.
139. Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, et al. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 2001;411:261-268.
140. Spencer RF, Porter JD. Structural organization of the extraocular muscles. In: Buttner-Ennever J, editor. Neuroanatomy of the oculomotor system. Amsterdam: Elsevier; 1988. p 33-79.
141. Stanley EF. Presynaptic calcium channels and the transmitter release mechanism. Ann NY Acad Sci 1993;681:368-372.
142. Sterz R, Pagala M, Peper K. Postjunctional characteristics of the endplates in mammalian fast and slow muscles. Pflügers Arch 1983;398:48-54.
143. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci 2004;27:509-547.
144. Sugiyama JE, Glass DJ, Yancopoulos GD, Hall ZW. Laminin-induced acetylcholine receptor clustering: an alternative pathway. J Cell Biol 1997;139:181-191.
145. 2+]. J Neurophysiol 2003;90:491-502.
146. Tang Y, Zucker RS. Mitochondrial involvement in post-tetanic potentiation of synaptic transmission. Neuron 1997;18:483-491.
147. Tanowitz M, Si J, Yu DH, Feng GS, Mei L. Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2. J Neurosci 1999;19:9426-9435.
148. Tello JF. Genesis de las terminaciounes nerviosas motrices y sensitivas. I. En el sistema locomotor de los vertebrados superiores. Madrid Univ Lab Invest Biol Trabajos 1917;15:101-199.
149. Tonge DA. Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscle of the mouse. J Physiol (Lond) 1974;241:127-139.
150. Trachtenberg JT, Thompson WJ. Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 1996;379:174-177.
151. Trinidad JC, Fischbach GD, Cohen JB. The Agrin/MuSK signaling pathway is spatially segregated from the neuregulin/ErbB receptor signaling pathway at the neuromuscular junction. J Neurosci 2000;20:8762-8770.
152. Uchitel O, Engel AG, Wals TJ, Nagel A, Atassi MZ, Bril V. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor. Musc Nerve 1993;16:1293-1301.
153. Unwin N. Projection structure of the nicotinic acetylcholine receptor: distinct conformations of the γ subunits. J Mol Biol 1996;257:586-596.
154. Van der Kloot W. Loading and recycling of synaptic vesicles in the Torpedo electric organ and the vertebrate neuromuscular junction. Prog Neurobiol 2003;71:269-303.
155. Vincent A, Newland C, Croxen R, Beeson D. Genes at the junction-candidates for congenital myasthenic syndrome. Trends Neurosci 1997;20:15-22.
156. Vulpian EF. Lecons sur la Physiologie Generale et Comparee du Systeme Nerveux. Paris: Bailliere; 1866.
157. Walrond JP, Reese TS. Structure of axon terminals and active zones at synapses on lizard twitch. J Neurosci 1985;5:1118-1131.
158. Winder S. Structure-function relationships in dystrophin and utrophin. Biochem Soc Trans 1996;24:497-501.
159. Winder SJ, Hemmings L, Maciver SK, Bolton SJ, Tinsley JM, Davies KE, et al. Utrophin actin binding domain: analysis of actin binding and cellular targeting. J Cell Sci 1995;108:63-71.
160. Woldeyesus MT, Britsch S, Riethmacher D, Xu L, Sonnenberg-Riethmacher E, Abou-Rebyeh F, et al. Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development. Genes Dev 1999;13:2538-2548.
161. Won S, Si J, Colledge M, Ravichandran KS, Froehner SC, Mei L. Neuregulin-increased expression of acetylcholine receptor epsilon-subunit gene requires ErbB interaction with She. J Neurochem 1999;73:2358-2368.
162. Wood S, Slater C. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. J Physiol (Lond) 1997;500:165-176.
163. Wood SJ, Slater CR. Safety factor at the neuromuscular junction. Prog Neurobiol 2001;64:393-429.
164. Yurchenco PD, O'Rear JJ. Basal lamina assembly. Curr Opin Cell Biol 1994;6:674-681.
165. Zhou H, Muramatsu T, Halfter W, Tsim KW, Peng HB. A role of midkine in the development of the neuromuscular junction. Mol Cell Neurosci 1997;10:56-70.